CAS ID: | 111025-46-8 |
Molecular Formula: | C19H20N2O3S |
Molecular Weight: | 356.5 g/mol |
Monoisotopic Mass: | 356.1195 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | GLIZOFAR | U-72107A | PIOGLITAZONE | GLIDIPION | PIOGLITAZONE HYDROCHLORIDE | Actos | Duetact | DIABIOM |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 23633075 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,rat | Fibrosis Disease | Cardiac fibrosis |
Process I | |||
Process II | |||
Process III | |||
Mechanism | Targeting miR-711-SP1 |
Reference Record 2
PubMed ID | 21127991 | Target ID | T0526 |
Uniprot ID | Peroxisome proliferator-activated receptor gamma | Name | Peroxisome proliferator-activated receptor gamma |
Model | vitro | Fibrosis Disease | Corneal fibrosis |
Process I | |||
Process II | cells proliferation,myofibroblasts differentiation | ||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting TGFβ |
Reference Record 3
Reference Record 4
Reference Record 5
Reference Record 6
Reference Record 7
PubMed ID | 24161914 | Target ID | |
Uniprot ID | Name | ||
Model | rat | Fibrosis Disease | Pulmonary fibrosis |
Process I | |||
Process II | fibroblasts accumulation | ||
Process III | prevenet collagen deposition | ||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT00719381 | Disease | Cystic fibrosis |
Phase | Phase 1 | Status | Completed |
First Received | July 21, 2008 | Last Verified | June 14, 2012 |
Sponsor | Paul Beringer |
Trial Record 2
ClinicalTrial ID | NCT00322868 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | May 8, 2006 | Last Verified | February 23, 2018 |
Sponsor | University Hospitals Cleveland Medical Center |
Trial Record 3
ClinicalTrial ID | NCT00531882 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | September 19, 2007 | Last Verified | October 5, 2017 |
Sponsor | University Hospitals Cleveland Medical Center |
Trial Record 4
ClinicalTrial ID | NCT00570622 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Completed |
First Received | December 11, 2007 | Last Verified | November 25, 2008 |
Sponsor | Medical University of Vienna |